The evidence reviewed for this guideline has highlighted the lack of useful national data on 19 pancreatic cancer in the UK. In many cancers, national datasets have contributed 20 significantly to improving outcomes of patient management. For pancreatic cancer, there has 21 been no comprehensive national database and therefore comparing outcomes between 22 pancreatic centres and pancreatic specialists has not been possible. This lack of continuous 23 audit may result in inappropriate variation in the standard of treatments between centres. The 24 Committee is of the unanimous opinion that a national database of pancreatic cancer 25 patients needs to be established to provide a continuous comparative audit of patient 26 management.
http://ift.tt/2oN3Q2B
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου